CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-1

The Basic Advocacy Training Session

The training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.

  1. Medication Assisted Treatment  Basic clinical information about methadone and buprenorphine treatment.

  2. Regulations and Accreditation The federal regulations will be explained:  What they are and how they relate to the state regulations? Accreditation and what an accreditation survey is, how it is done, and how advocates can be involved.

  3. The Basics of Advocacy The different kinds of advocacy from “Hands On” Individual Advocacy (handling a grievavce), Networking, Systems Advocacy, Working with Policy Makers and Politicians.

  4. Stigma and Prejudice Patients themselves are often the greatest spreaders of stigma through ignorance and myths. Stigma will only end when society is educated about the effectiveness and benefits of MAT from the bottom up. We need to start with patients who can become ambassadors for MAT but this will be most effective with the support of policy makers and regulating agencies. The Media also spreads misinformation and stigma about MAT. Advocates need to have basic skills to work with the Media and write an Editorial, Letter to the Editor LTE and a Press Release.

  5. Advocate Certification What is certification and how it will professionalize those committed to MAT advocacy.  The Advocates Code of Ethics, the Goals of MAT Advocacy, and Advocate Certification.

Similar Posts

  • CERTIFIED METHADONE ADVOCATE (CMA)

    Admin 03/21/2023

    Methadone Advocacy The National Alliance of Methadone Advocates (NAMA) holds the view that every individual who believes in methadone treatment is at least a potential Certified Methadone Advocate (CMA). We encourage all supporters of methadone treatment, patient and non-patient, to become Certified Methadone Advocates so that all energies directed toward the advancement of methadone treatment…

  • Email Protection

    Admin 08/08/2022

    Please enable cookies. You are unable to access this email address Methadone.org The website from which you got to this page is protected by Cloudflare. Email addresses on that page have been hidden in order to keep them from being accessed by malicious bots. You must enable Javascript in your browser in order to decode…

  • Policy Statements

    Admin 11/02/2021

    Policy Statement 1 Methadone Medical Maintenance April 1994 Download File  (pdf format) Policy Statement 2 The Policy of Blind Dosing and Patient Dignity April 18, 1994 Download File (pdf format) Policy Statement 3 Discharge From Treatment for Drug Use May 1994 Download File (pdf format) Policy Statement 4 Patient vs Client May 1994 Download File (pdf format) Policy…

  • Recertification

    Admin 04/06/2021

    Recertify for Your Medication Assisted Treatment Advocate (CMA) About Recertification We have had many persons who are certified contact us about recertification. Previously the only way to recertify was to take the training again. There have been some CMAs who saw their certification as so valuable that they have taken the training again. Steps to…

  • Page 4098 Federal Register

    Admin 08/28/2021

     Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i)                 Unsupervised or take-home use.   To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements.   (1)   Any patient…